Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety

References

• LiuZDoanQVBlumenthalPDuboisRWA systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in abnormal uterine bleedingValue Health200710318319417532811
   PubMed Web of Science ®Google Scholar
• ReesMMenorrhagiaBr Med J (Clin Res Ed)19872946574759762
   Web of Science ®Google Scholar
• HallbergLHögdahlAMNilssonLRyboGMenstrual blood loss–a population study. Variation at different ages and attempts to define normalityActa Obstet Gynecol Scand19664533203515922481
   PubMed Web of Science ®Google Scholar
• WyattKMDimmockPWWalkerTJO’BrienPMDetermination of total menstrual blood lossFertil Steril200176112513111438330
   PubMed Web of Science ®Google Scholar
• http://www.fda.gov [homepage on the Internet]US Food and Drug AdministrationDrugs@FDA: Lysteda (tranexamic acid) label information Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022430s002lbl.pdfAccessed March 19, 2012
   Google Scholar
• WellingtonKWagstaffAJTranexamic acid: A review of its use in the management of menorrhagiaDrugs200363131417143312825966
   PubMed Web of Science ®Google Scholar
• TapariaMCordingleyFTLeahyMFPulmonary embolism associated with tranexamic acid in severe acquired haemophiliaEur J Haematol200268530730912144537
   PubMed Web of Science ®Google Scholar
• WooKSTseLKWooJLVallance-OwenJMassive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapyBr J Clin Pract198943124654662611113
   PubMedGoogle Scholar
• DawoodMHuangJUterine vascular function and menstruationCurr Obstet Gynaecol1998826672
   Google Scholar
• MarkeeJEMorphological basis for menstrual bleeding; relation of regression to the initiation of bleedingBull N Y Acad Med194824425326818909518
   PubMedGoogle Scholar
• RogersPALedermanFTaylorNEndometrial microvascular growth in normal and dysfunctional statesHum Reprod Update19984550350810027602
   PubMed Web of Science ®Google Scholar
• FerenczyABertrandGGelfandMMProliferation kinetics of human endometrium during the normal menstrual cycleAm J Obstet Gynecol19791338859867434029
   PubMed Web of Science ®Google Scholar
• SmithSKAbelMHKellyRWBairdDTProstaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleedingBr J Obstet Gynaecol19818844344427225303
   PubMedGoogle Scholar
• WangIYFraserISBarsamianSPEndometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum womenMol Hum Reprod20006325826310694274
   PubMed Web of Science ®Google Scholar
• RyboGPlasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood lossActa Obstet Gynecol Scand19664544294505955253
   PubMed Web of Science ®Google Scholar
• HefnawiFSalehAKandilOEl-SheikhaZHassaneinMAskalaniHFibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the lippes loop and the cu-T (200)Int J Gynaecol Obstet197916540040735409
   PubMedGoogle Scholar
• GleesonNCBuggyFSheppardBLBonnarJThe effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleedingActa Obstet Gynecol Scand19947332742778122512
   PubMed Web of Science ®Google Scholar
• DockerayCJSheppardBLDalyLBonnarJThe fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acidEur J Obstet Gynecol Reprod Biol19872443093182953634
   PubMed Web of Science ®Google Scholar
• BenoniGBjörkmanSFredinHApplication of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patientsClin Drug Invest1995105280287
   Web of Science ®Google Scholar
• ErikssonOKjellmanHPilbrantASchannongMPharmacokinetics of tranexamic acid after intravenous administration to normal volunteersEur J Clin Pharmacol1974753753804422030
   PubMed Web of Science ®Google Scholar
• PilbrantASchannongMVessmanJPharmacokinetics and bioavailability of tranexamic acidEur J Clin Pharmacol198120165727308275
   PubMed Web of Science ®Google Scholar
• http://www.ema.europa.eu [homepage on the Internet]European Medicines AgencyCommittee for proprietary medicinal products (CPMP) opinion following an article 10 referral: CYKLO-f (tranexamic acid) Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Cyklo-f/human_referral_000097.jsp&mid=WC0b01ac0580024e9a#Accessed March 19, 2012
   Google Scholar
• AnderschBMilsomIRyboGAn objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagiaActa Obstet Gynecol Scand19886776456483073625
   PubMed Web of Science ®Google Scholar
• BonnarJSheppardBLTreatment of menorrhagia during menstruation: Randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acidBMJ199631370575795828806245
   PubMed Web of Science ®Google Scholar
• CallenderSTWarnerGTCopeETreatment of menorrhagia with tranexamic acid. A double-blind trialBr Med J1970457292142164919554
   PubMed Web of Science ®Google Scholar
• FreemanEWLukesAVanDrieDMabeyRGGerstenJAdomakoTLA dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleedingAm J Obstet Gynecol20112054319.e1319.e721777897
   PubMed Web of Science ®Google Scholar
• KouidesPAByamsVRPhilippCSMultisite management study of menorrhagia with abnormal laboratory haemostasis: A prospective crossover study of intranasal desmopressin and oral tranexamic acidBr J Haematol2009145221222019236375
   PubMed Web of Science ®Google Scholar
• KriplaniAKulshresthaVAgarwalNDiwakarSRole of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetateJ Obstet Gynaecol200626767367817071438
   PubMedGoogle Scholar
• LukesASMooreKAMuseKNTranexamic acid treatment for heavy menstrual bleeding: A randomized controlled trialObstet Gynecol2010116486587520859150
   PubMed Web of Science ®Google Scholar
• MilsomIAnderssonKAnderschBRyboGA comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagiaAm J Obstet Gynecol199116438798831900665
   PubMed Web of Science ®Google Scholar
• NilssonLRyboGTreatment of menorrhagia with an antifibrinolytic agent, tranexamic acid (AMCA): A double blind investigationActa Obstet Gynecol Scand1967464572580
   Web of Science ®Google Scholar
• PrestonJTCameronITAdamsEJSmithSKComparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagiaBr J Obstet Gynaecol199510254014067612535
   PubMedGoogle Scholar
• VermylenJVerhaegen-DeclercqMLVerstraeteMFierensFA double blind study of the effect of tranexamic acid in essential menorrhagiaThromb Diath Haemorrh19682035835875710474
   PubMedGoogle Scholar
• HallbergLNilssonLDetermination of menstrual blood lossScand J Clin Lab Invest19641624424814161862
   PubMed Web of Science ®Google Scholar
• HighamJMO’BrienPMShawRWAssessment of menstrual blood loss using a pictorial chartBr J Obstet Gynaecol19909787347392400752
   PubMedGoogle Scholar
• JanssenCAScholtenPCHeintzAPA simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood lossObstet Gynecol19958569779827770270
   PubMed Web of Science ®Google Scholar
• LukesASMuseKRichterHEMooreKAPatrickDLEstimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleedingCurr Med Res Opin201026112673267820942615
   PubMed Web of Science ®Google Scholar
• WinklerUHThe effect of tranexamic acid on the quality of life of women with heavy menstrual bleedingEur J Obstet Gynecol Reprod Biol200199223824311788179
   PubMed Web of Science ®Google Scholar
• MuseKLukesASGerstenJWaldbaumAMabeyRGTrottELong-term evaluation of safety and health-related quality of life in women with heavy menstrual bleeding treated with oral tranexamic acidWomens Health (Lond Engl)20117669970721867401
   PubMedGoogle Scholar
• LethabyAFarquharCCookeIAntifibrinolytics for heavy menstrual bleedingCochrane Database Syst Rev20004CD00024911034679
   PubMedGoogle Scholar
• BerntorpEFollrudCLethagenSNo increased risk of venous thrombosis in women taking tranexamic acidThromb Haemost200186271471511522029
   PubMed Web of Science ®Google Scholar
• RyboGTranexamic acid therapy: Effective treatment in heavy menstrual bleeding. Clinical update on safetyTherapeutic Advances1991418
   Google Scholar
• SundströmASeamanHKielerHAlfredssonLThe risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: A case-control study using the General Practice Research DatabaseBJOG20091161919719016686
   PubMed Web of Science ®Google Scholar
• KirschnerRA cost-benefit analysis of different therapeutic methods in menorrhagiaTidsskr Nor Laegeforen199511556186217900119
   PubMedGoogle Scholar
• National Collaborating Centre for Women’s and Children’s Health (UK)Heavy Menstrual BleedingLondonRCOG Press2007
   Google Scholar